$0.702
-0.028 (-4.01%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Metagenomi Therapeutics Inc (MGX) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting MGX is Strong sell.
Metagenomi Therapeutics Inc (MGX) 20-Day simple moving average is 0.81, while Metagenomi Therapeutics Inc (MGX) share price is $—, making it Sell.
Metagenomi Therapeutics Inc (MGX) 60-Day simple moving average is 1.03, while Metagenomi Therapeutics Inc (MGX) share price is $—, making it Sell.
Technical Analysis for MGX
AI Technical MGXAs of 2026-11-07, the technical board for Metagenomi Therapeutics Inc (MGX) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $0.70 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 28.816, MACD stands at -0.0747 (Sell), Stochastic %K stands at 30.596, Stochastic %D stands at 27.922 and CCI stands at -186.264 (Buy).
MGX trades below the 60-day SMA (1.03) and below the 200-day SMA (1.27). Immediate resistance sits at Classic R1 0.91, then R2 1.04. Support sits at Classic S1 0.62, then S2 0.47.
Metagenomi Therapeutics Inc (MGX) Support & Resistance Level
Metagenomi Therapeutics Inc (MGX) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 28.816 |
| STOCHk_14_3_3 | 30.596 |
| STOCHd_14_3_3 | 27.922 |
| CCI_20 | -186.264 |
| AO_5_34 | -0.179 |
| MOM_10 | -0.096 |
| MACD_12_26_9 | -0.075 |
Metagenomi Therapeutics Inc (MGX) Relative Strength Index (RSI_14) is 28.816, creating a Buy signal.
Metagenomi Therapeutics Inc (MGX) Stochastic %K is 30.596, creating a Neutral signal.
Metagenomi Therapeutics Inc (MGX) Stochastic %D is 27.922, creating a Neutral signal.
Metagenomi Therapeutics Inc (MGX) CCI_20 is -186.264, creating a Buy signal.
Metagenomi Therapeutics Inc (MGX) Awesome Oscillator (AO) is -0.179, creating a Sell signal.
Metagenomi Therapeutics Inc (MGX) Momentum (MOM) is -0.096, creating a Sell signal.
Metagenomi Therapeutics Inc (MGX) Moving Average Convergence Divergence (MACD) is -0.075, creating a Sell signal.
Metagenomi Therapeutics Inc (MGX) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.749 | Sell |
| MA_10 | 0.774 | Sell |
| MA_20 | 0.813 | Sell |
| MA_60 | 1.034 | Sell |
| MA_200 | 1.270 | Sell |
| MA_250 | 1.360 | Sell |
Metagenomi Therapeutics Inc (MGX) 5-Day simple moving average is 0.749, while Metagenomi Therapeutics Inc (MGX) share price is $, making it a Sell.
Metagenomi Therapeutics Inc (MGX) 10-Day simple moving average is 0.774, while Metagenomi Therapeutics Inc (MGX) share price is $, making it a Sell.
Metagenomi Therapeutics Inc (MGX) 20-Day simple moving average is 0.813, while Metagenomi Therapeutics Inc (MGX) share price is $, making it a Sell.
Metagenomi Therapeutics Inc (MGX) 60-Day simple moving average is 1.034, while Metagenomi Therapeutics Inc (MGX) share price is $, making it a Sell.
Metagenomi Therapeutics Inc (MGX) 200-Day simple moving average is 1.270, while Metagenomi Therapeutics Inc (MGX) share price is $, making it a Sell.
Metagenomi Therapeutics Inc (MGX) 250-Day simple moving average is 1.360, while Metagenomi Therapeutics Inc (MGX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.